{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:45:30Z","timestamp":1794584730753,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.survophthal.2026.02.010","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:17:37Z","timestamp":1771949857000},"page":"1384-1395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence"],"prefix":"10.1016","volume":"71","author":[{"given":"Felipe","family":"Murati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parichehr","family":"Ghahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawanda","family":"Zvavamwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyatt W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-0017","authenticated-orcid":false,"given":"Igor","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.survophthal.2026.02.010_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial.","volume":"309","author":"Age-Related Eye Disease Study 2 Research Group","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.survophthal.2026.02.010_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.010_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1125784","article-title":"Diabetic rats with high levels of endogenous dopamine do not show retinal vascular pathology","volume":"17","author":"Allen","year":"2023","journal-title":"Front Neurosci"},{"issue":"296","key":"10.1016\/j.survophthal.2026.02.010_bib4","doi-asserted-by":"crossref","first-page":"ra89","DOI":"10.1126\/scisignal.2004302","article-title":"Heteromeric MT1\/MT2 melatonin receptors modulate photoreceptor function","volume":"6","author":"Baba","year":"2013","journal-title":"Sci Signal"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.010_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjmed.2015.10.015","article-title":"Mining retrospective data for virtual prospective drug repurposing: L-DOPA and age-related macular degeneration","volume":"129","author":"Brilliant","year":"2016","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.010_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40662-024-00412-2","article-title":"Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degeneration","volume":"11","author":"Chan","year":"2024","journal-title":"Eye Vis (Lond)"},{"key":"10.1016\/j.survophthal.2026.02.010_bib7","article-title":"Levodopa and dopamine agonists in neovascular age-related macular degeneration in the sight outcomes research collaborative database","author":"Chan","year":"2025","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2026.02.010_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-vision-111022-123810","article-title":"Visual dysfunction in diabetes","volume":"9","author":"Eggers","year":"2023","journal-title":"Annu Rev Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.010_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/IAE.0b013e31821e2070","article-title":"Rasagiline interferes with neurodegeneration in the Prph2\/rds mouse","volume":"32","author":"Eigeldinger-Berthou","year":"2012","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.010_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjmed.2020.05.038","article-title":"Levodopa positively affects neovascular age-related macular degeneration","volume":"134","author":"Figueroa","year":"2021","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.010_bib11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/cns.12805","article-title":"Rasagiline delays retinal degeneration in a mouse model of retinitis pigmentosa via modulation of Bax\/Bcl-2 expression","volume":"24","author":"Garcia-Delgado","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.survophthal.2026.02.010_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.647541","article-title":"Dopamine-mediated circadian and light\/dark-adaptive modulation of chemical and electrical synapses in the outer retina","volume":"15","author":"Goel","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.survophthal.2026.02.010_bib13","first-page":"129","article-title":"Levodopa is associated with reduced development of neovascular age-related macular degeneration","volume":"246","author":"Hyman","year":"2023","journal-title":"Ophthalmol Retin"},{"issue":"5","key":"10.1016\/j.survophthal.2026.02.010_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.preteyeres.2005.01.003","article-title":"Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina","volume":"24","author":"Iuvone","year":"2005","journal-title":"Prog Retin Eye Res"},{"issue":"27","key":"10.1016\/j.survophthal.2026.02.010_bib15","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1523\/JNEUROSCI.0711-12.2012","article-title":"Retinal dopamine mediates multiple dimensions of light-adapted vision","volume":"32","author":"Jackson","year":"2012","journal-title":"J Neurosci"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.010_bib16","first-page":"945","article-title":"C5 inhibitor avacincaptad pegol in geographic atrophy secondary to AMD: a randomized pivotal trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.010_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0161-6420(99)00133-5","article-title":"Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy","volume":"107","author":"Johnson","year":"2000","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.010_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1167\/iovs.17-22692","article-title":"Dopamine deficiency mediates early rod-driven inner retinal dysfunction in diabetic mice","volume":"59","author":"Kim","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.010_bib19","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200865R","article-title":"Dopamine ameliorates hyperglycemic memory-induced microvascular dysfunction in diabetic retinopathy","volume":"36","author":"Lee","year":"2022","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.010_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/0191-3913-19950501-05","article-title":"Levodopa\/carbidopa treatment for amblyopia in older children","volume":"32","author":"Leguire","year":"1995","journal-title":"J Pedia Ophthalmol Strabismus"},{"issue":"9","key":"10.1016\/j.survophthal.2026.02.010_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060236","article-title":"L-DOPA is an endogenous ligand for OA1","volume":"6","author":"Lopez","year":"2008","journal-title":"PLoS Biol"},{"issue":"17","key":"10.1016\/j.survophthal.2026.02.010_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174199","article-title":"DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration","volume":"134","author":"Mathis","year":"2024","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.010_bib23","first-page":"13","article-title":"Pigmentation and ocular health: the role of GPR143","volume":"97","author":"McKay","year":"2019","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.survophthal.2026.02.010_bib24","series-title":"Glaucoma Research and Clinical Advances: 2018\u20132020","first-page":"99","article-title":"Is there a final common pathway affected in POAG?","author":"McKay","year":"2018"},{"issue":"12","key":"10.1016\/j.survophthal.2026.02.010_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082301","article-title":"A role for myocilin in receptor-mediated endocytosis","volume":"8","author":"McKay","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.010_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3928\/23258160-20250326-02","article-title":"Dopaminergic therapies may decrease risk of early and intermediate non-exudative age-related macular degeneration progression","volume":"56","author":"Morgan","year":"2025","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"7","key":"10.1016\/j.survophthal.2026.02.010_bib27","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/db19-0869","article-title":"Novel detection and restorative levodopa treatment for preclinical diabetic retinopathy","volume":"69","author":"Motz","year":"2020","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.survophthal.2026.02.010_bib28","doi-asserted-by":"crossref","first-page":"13196","DOI":"10.3390\/ijms252313196","article-title":"Dopamine: a new player in the pathogenesis of diabetic retinopathy?","volume":"25","author":"Ntikoudi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.02.010_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057184","article-title":"L-Dopa and the albino riddle: content of L-Dopa in the developing retina of pigmented and albino mice","volume":"8","author":"Roffler-Tarlov","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.010_bib30","first-page":"425","article-title":"Depression and functional vision loss in patients with age-related macular degeneration","volume":"4","author":"Rovner","year":"1996","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.survophthal.2026.02.010_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44373-3","article-title":"Human equivalent doses of L-DOPA rescue retinal morphology and visual function in a murine model of albinism","volume":"13","author":"Sanchez-Bretano","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2026.02.010_bib32","doi-asserted-by":"crossref","first-page":"H1554","DOI":"10.1152\/ajpheart.00272.2004","article-title":"Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells","volume":"287","author":"Sarkar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.survophthal.2026.02.010_bib33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exer.2015.07.007","article-title":"Beneficial protective effect of pramipexole on light-induced retinal damage in mice","volume":"139","author":"Shibagaki","year":"2015","journal-title":"Exp Eye Res"},{"issue":"Pt 18","key":"10.1016\/j.survophthal.2026.02.010_bib34","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1242\/jcs.053124","article-title":"Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2","volume":"122","author":"Sinha","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.survophthal.2026.02.010_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.103888.3","article-title":"Sex-specific attenuation of photoreceptor degeneration by reserpine in a rhodopsin P23H rat model of autosomal dominant retinitis pigmentosa","volume":"14","author":"Song","year":"2025","journal-title":"ELife"},{"issue":"8","key":"10.1016\/j.survophthal.2026.02.010_bib36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/ceo.12325","article-title":"Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial","volume":"42","author":"Summers","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.02.010_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54789-5","article-title":"Effectiveness and safety of topical levodopa in a chick model of myopia","volume":"9","author":"Thomson","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.survophthal.2026.02.010_bib38","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1111\/cts.13392","article-title":"The safety and tolerability of levodopa eye drops for the treatment of ocular disorders: a randomized first-in-human study","volume":"15","author":"Thomson","year":"2022","journal-title":"Clin Transl Scil"},{"key":"10.1016\/j.survophthal.2026.02.010_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-031-27681-1_7","article-title":"Decoding race and age-related macular degeneration: GPR 143 activity is the key","volume":"1415","author":"Tung","year":"2023","journal-title":"Ophthalmol Sci Adv Exp Med Biol"},{"key":"10.1016\/j.survophthal.2026.02.010_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110781","article-title":"Dopamine receptor-mediated roles on retinal ganglion cell hyperexcitability and injury in experimental glaucoma","volume":"109","author":"Yin","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.survophthal.2026.02.010_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/24741264251330338","article-title":"Possible association between dopamine antagonists and increased conversion to exudative age-related macular degeneration","author":"Weng","year":"2025","journal-title":"J Vitreoretin Dis"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962572600024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962572600024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:58:19Z","timestamp":1784278699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003962572600024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S003962572600024X"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.02.010","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levodopa in retinal disease: Dopamine pathways, neuroprotective mechanisms, and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}